A study of 181 patients at 16 sites across the country who test negative for two antibodies long known to cause muscle-weakening myasthenia gravis, found that about 15% test positive for one of two newly discovered antibodies that also attack the...
"It's potentially a really safe way to treat inflammatory disease," said Dr. Paul O'Connor, the study’s co-author from the Medical College of Georgia at Augusta University.